LENEXA, Kan. – (April 1, 2015) – The Mid-America Angels investment network (MAA) deployed over $870,000 in commercialization funding in Q1 of 2015. This puts MAA on pace to exceed the $2.3 million members of the network invested in six deals last year. MAA’s Q1 activity included a $696,000 investment in Olathe, Kan.-based TVAX Animal Health and a $178,000 investment, led by the Women’s Capital Connection, in Kansas City, Mo.-based Rawxies, a raw, vegan food product company.
“We’re proud to welcome two additional companies to our MAA portfolio, and look forward to working with the management teams of TVAX Animal Health and Rawxies to ensure both their continued growth and job growth in our region,” said George Hansen, President and CEO of the Enterprise Center of Johnson County (ECJC). The ECJC manages the Mid-America Angels network.
“With such a huge potential in the U.S. veterinary market for effective cancer treatment options, we’re extremely pleased Mid-America Angels invested in the TVAX Animal Health vision,” said Tammie Wahaus, CEO of TVAX Animal Health. “Their support gives us additional resources to further the development of our novel targeted T cell based therapy.”
Rawxies is an all-natural, gluten-free, raw line of food products. The recent investment will help CEO Callie England build sales and marketing capabilities and expand new product lines.
About the Mid-America Angels.
Mid-America Angels, LLC is an angel investor network focused on early-stage, high-growth companies in the Kansas and Missouri region. Since its inception in 2006, the angel group has made 62 investments totaling over $16 million. Individuals interested in more information about becoming a member of MAA or applying for funding, visit, www.midamericaangels.com.
Mid-America Angels is managed by the Enterprise Center of Johnson County, a non-profit venture development organization providing advisory services, access to funding resources, entrepreneurial education, flexible office space and networking connections for high-growth companies. For more information, visit www.ecjc.com.
About TVAX Animal Health
Based in Olathe, Kan., TVAX Biomedical, Inc., is a clinical stage development company advancing its targeted T cell-based immunotherapy for the treatment of cancer. The company’s novel therapeutic approach offers the promise of improved clinical outcomes, low toxicity and the potential for fundamentally changing the way cancer is treated. TVAX Animal Health, a subsidiary of TVAX Biomedical, Inc., is focused on adapting the TVAX Immunotherapy® for applications in the veterinary sector with an initial focus on cancer in dogs. For more information, please visit www.tvaxbiomedical.com.
Rawxies provides the health conscious consumer with an all-natural product that is gluten-free and prepared at low temperatures to preserve optimal enzymatic qualities. Rawxies are a unique hybrid between a nutritional food bar and an indulgent dessert. Rawxies have been nationally awarded ‘Top 6 Vegan Products 2013’ at Natural Product’s Expo West in Anaheim, CA, “Best of Raw 2013, Best Cookie”, and “Dean & Deluca Top Pick 2014” in New York City. For more information, please visit www.rawxies.com.